- Home
- AVIR vs TSI Comparison
AVIR vs TSI Comparison
Compare AVIR & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- TSI
- Stock Information
- Founded
- AVIR 2012
- TSI 1987
- Country
- AVIR United States
- TSI United States
- Employees
- AVIR N/A
- TSI N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- TSI Investment Managers
- Sector
- AVIR Health Care
- TSI Finance
- Exchange
- AVIR Nasdaq
- TSI Nasdaq
- Market Cap
- AVIR 247.5M
- TSI 241.8M
- IPO Year
- AVIR 2020
- TSI N/A
- Fundamental
- Price
- AVIR $3.29
- TSI $5.01
- Analyst Decision
- AVIR Hold
- TSI
- Analyst Count
- AVIR 1
- TSI 0
- Target Price
- AVIR $6.88
- TSI N/A
- AVG Volume (30 Days)
- AVIR 491.5K
- TSI 106.8K
- Earning Date
- AVIR 11-07-2024
- TSI 01-01-0001
- Dividend Yield
- AVIR N/A
- TSI 7.46%
- EPS Growth
- AVIR N/A
- TSI N/A
- EPS
- AVIR N/A
- TSI N/A
- Revenue
- AVIR N/A
- TSI N/A
- Revenue This Year
- AVIR N/A
- TSI N/A
- Revenue Next Year
- AVIR N/A
- TSI N/A
- P/E Ratio
- AVIR N/A
- TSI N/A
- Revenue Growth
- AVIR N/A
- TSI N/A
- 52 Week Low
- AVIR $2.75
- TSI $4.48
- 52 Week High
- AVIR $4.60
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- AVIR 49.07
- TSI 50.11
- Support Level
- AVIR $3.10
- TSI $4.98
- Resistance Level
- AVIR $3.27
- TSI $5.07
- Average True Range (ATR)
- AVIR 0.16
- TSI 0.03
- MACD
- AVIR 0.02
- TSI -0.00
- Stochastic Oscillator
- AVIR 55.28
- TSI 33.33
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.